KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Cardinal Health (CAH) EBIAT (2016 - 2025)

Cardinal Health's EBIAT history spans 17 years, with the latest figure at $471.0 million for Q4 2025.

  • For Q4 2025, EBIAT rose 17.46% year-over-year to $471.0 million; the TTM value through Dec 2025 reached $1.7 billion, up 17.04%, while the annual FY2025 figure was $1.6 billion, 83.94% up from the prior year.
  • EBIAT for Q4 2025 was $471.0 million at Cardinal Health, up from $454.0 million in the prior quarter.
  • Across five years, EBIAT topped out at $508.0 million in Q1 2025 and bottomed at -$1.4 billion in Q1 2022.
  • The 5-year median for EBIAT is $251.0 million (2024), against an average of $155.0 million.
  • The largest annual shift saw EBIAT tumbled 1259.17% in 2022 before it skyrocketed 3890.91% in 2024.
  • A 5-year view of EBIAT shows it stood at $49.0 million in 2021, then crashed by 257.14% to -$77.0 million in 2022, then skyrocketed by 579.22% to $369.0 million in 2023, then increased by 8.67% to $401.0 million in 2024, then increased by 17.46% to $471.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's EBIAT are $471.0 million (Q4 2025), $454.0 million (Q3 2025), and $243.0 million (Q2 2025).